Thermo Fisher Scientific Inc. is the world leader in serving science, enabling customers to make the world healthier, cleaner, and safer. The company provides innovative technologies, purchasing convenience, and pharmaceutical services through brands including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. It serves pharmaceutical, biotech, clinical, academic, government, environmental, and industrial markets through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services.
Q2 FY2026 — expected 2026-09-15
| Type | Subject | Detail | Quarter |
|---|---|---|---|
| topic_mention | TMO | discussed Cybersecurity | |
| topic_mention | TMO | discussed Healthcare & Bio | |
| topic_mention | TMO | discussed Artificial Intelligence | |
| topic_mention | TMO | discussed Blockchain & Crypto | |
| topic_mention | TMO | discussed Semiconductor | |
| topic_mention | TMO | discussed Capital Expenditure | |
| topic_mention | TMO | discussed Supply Chain | |
| topic_mention | TMO | discussed Regulation | |
| topic_mention | TMO | discussed Sovereign & Government | |
| topic_mention | TMO | discussed Automotive | |
| topic_mention | TMO | discussed Healthcare & Bio | |
| topic_mention | TMO | discussed AI Compute | |
| topic_mention | TMO | discussed Platform & Ecosystem | |
| metric | TMO gross margin | reported $22.5 percent | |
| metric | TMO gross margin | reported $32.0 percent | |
| metric | TMO gross margin | reported $24.4 percent | |
| metric | TMO gross margin | reported $25.3 percent | |
| metric | TMO gross margin | reported $13.8 percent | |
| metric | TMO EPS | reported $21.29 | |
| outlook | TMO | stated we expect to deploy over time • Fully fund high-ROI organic opex and capex opportunities • M&A is the primary focus of our capital deployment strategy • |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0000097745-26-000018 | EDGAR | 55K words |
| 2025-02-20 | 2024-12-31 | 0000097745-25-000010 | EDGAR | — |
| 2024-02-22 | 2023-12-31 | 0000097745-24-000007 | EDGAR | — |
| 2023-02-23 | 2022-12-31 | 0000097745-23-000008 | EDGAR | — |
| 2022-02-24 | 2021-12-31 | 0000097745-22-000011 | EDGAR | — |
| 2021-02-25 | 2020-12-31 | 0000097745-21-000011 | EDGAR | — |
| 2020-02-26 | 2019-12-31 | 0000097745-20-000009 | EDGAR | — |
| 2019-02-27 | 2018-12-31 | 0000097745-19-000007 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-10-31 | 2025-09-27 | 0000097745-25-000159 | EDGAR | 22K words |
| 2025-08-01 | 2025-06-28 | 0000097745-25-000101 | EDGAR | — |
| 2025-05-02 | 2025-03-29 | 0000097745-25-000041 | EDGAR | — |
| 2024-11-01 | 2024-09-28 | 0000097745-24-000046 | EDGAR | — |
| 2024-08-02 | 2024-06-29 | 0000097745-24-000040 | EDGAR | — |
| 2024-05-03 | 2024-03-30 | 0000097745-24-000023 | EDGAR | — |
| 2023-11-03 | 2023-09-30 | 0000097745-23-000069 | EDGAR | — |
| 2023-08-04 | 2023-07-01 | 0000097745-23-000059 | EDGAR | — |
| 2023-05-05 | 2023-04-01 | 0000097745-23-000033 | EDGAR | — |
| 2022-11-04 | 2022-10-01 | 0000097745-22-000057 | EDGAR | — |
| 2022-08-05 | 2022-07-02 | 0000097745-22-000047 | EDGAR | — |
| 2022-05-06 | 2022-04-02 | 0000097745-22-000027 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-24 | 0000097745-26-000066 | EDGAR | 1K words |
| 2026-02-12 | 0001140361-26-005014 | EDGAR | — |
| 2026-01-29 | 0000097745-26-000012 | EDGAR | — |
| 2026-01-12 | 0001140361-26-000871 | EDGAR | — |
| 2025-12-01 | 0001140361-25-043790 | EDGAR | — |
| 2025-10-29 | 0000097745-25-000156 | EDGAR | — |
| 2025-10-22 | 0000097745-25-000150 | EDGAR | — |
| 2025-10-07 | 0001140361-25-037501 | EDGAR | — |
| 2025-09-02 | 0000097745-25-000111 | EDGAR | — |
| 2025-07-23 | 0000097745-25-000095 | EDGAR | — |
167 total filings indexed. 137 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| Call Date | Quarter | Title |
|---|---|---|
| — | TMO Earnings Call Transcript | |
| — | TMO Earnings Call Transcript | |
| — | TMO Earnings Call Transcript | |
| — | Q1 FY2021 | TMO Q1 FY2021 Earnings Call Transcript |
| — | TMO Earnings Call Transcript | |
| — | TMO Earnings Call Transcript | |
| — | TMO Earnings Call Transcript | |
| — | TMO Earnings Call Transcript | |
| — | Q3 FY2021 | TMO Q3 FY2021 Earnings Call Transcript |
| — | TMO Earnings Call Transcript | |
| — | TMO Earnings Call Transcript | |
| — | Q4 FY2025 | TMO Q4 FY2025 Earnings Call Transcript |
2 more transcripts.
Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.
| CIK | 0000097745 |
| Ticker | TMO |
| Exchange | NYSE |
| SIC | 3829: Measuring & Controlling Devices, NEC |
| Incorporated | DE |
| Website | https://www.thermofisher.com |
| Listed | 1972-06-01 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report